He has gotten large donations from and owns hundreds of thousands of dollars in stocks in drug and medical device companies.

When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor’s total average return is 819% — a market-crushing outperformance compared to 170% for the S&P 500.* They just ...

Altogether, 26 funds focused on pharma and healthcare collectively manage Rs 30,306 crore. Some of them offer exposure to ...

The study indicated that pharma ads can have a practical impact on disease awareness and the care journey for patients.

Indian shares fell on Tuesday, weighed down by auto and pharma stocks, while caution prevailed due to a largely tepid ...

Now, the long-time business leader’s next project, dubbed Ottimo Pharma, has emerged after three years in stealth with a ...

The business reported a 13% growth in India revenues to ₹1,632 Crore, driven by outperformance in focus therapies.

OKYO Pharma Limited (NASDAQ: OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the ...

Evoke Pharma reports positive results for a study on GIMOTI. Evoke Pharma stock has now tripled since early September.

Tyr Pharma has a pivotal year ahead with key readouts for Efzofitimod, potentially opening a huge market. Find out why ATYR ...

Torrent Group was actively pursuing the acquisition of Cipla and JB Chemicals and Pharmaceuticals but ultimately withdrew due to high valuations demanded by the sellers ...

AM(IST)on Wednesday in a weak market. Mankind Pharma Ltd.(up 3.92 per cent), Natco Pharma Ltd.(up 2.25 per cent), Gland ...